Figures computed from official regulatory filings — .
Ownershipinsiders 64.82% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Zhong Yuan Bio-Technology Holdings Ltd only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited is based in Wan Chai, Hong Kong.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| CASSIDY JAMES M | Sell | $9.5B | SEC | ||
| McKillop James K |
| Sell |
| $9.5B |
| SEC |